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Abbreviations
APTMS -  3-Aminopropyl-Trimethoxysilane
CT -  X-ray Computed Tomography
DAB - 3,3'-Diaminobenzidine
DLS -  Dynamic Light Scattering
DMEM - Dulbecco's Modified Eagle Medium 
ELSD - Evaporative Light Scattering Detector
EPR -  Enhanced Permeability and Retention
FBS -  Fetal Bovine Serum
Fe - iron
HASMC - Human Aortic Smooth Muscle Cells
HeLa - Human cervical cancer cell
HepG2 - Human Hepatocellular carcinoma cell 
line
HMEC - Human Mammary Epithelial Cells
HPLC - High-Performance Liquid 
Chromatography
HUVEC - Human Umbilical Vein Endothelial 
Cell
ICP-AES -  Inductively Coupled Plasma Atomic 
Emission Spectroscopy
IgG - Immunoglobulin G
IXGp - Ion-X-Gel precursor
Jurkat - Immortalized human T lymphocyte
L929 - Immortalized rat fibroblast
MDA-MB-231 -  Human breast carcinoma cells
MRI - Magnetic Resonance Imaging
NMR - Nuclear Magnetic Resonance
NMV -  Net Magnetization Vector
NSF -  Nephrogenic Systemic Fibrosis
P - phosphate
PANC1 -  Human Pancreatic Carcinoma cells
PBS - Phosphate Buffered Saline
PEG -  Polyethylene Glycol
PET -  Positron Emission Tomography
RAW264.7 - Immortalized rat macrophage
RES -  Reticuloendothelial System
RF - Radio Frequency
RPMI - Roswell Park Memorial Institute medium
Si - silicon
SPIO -  Super-Paramagnetic Iron Oxide
T1 - Time constant for recovery of NMV back to 
longitudinal plane
T2 - Time constant for NMV decay in the 
transverse plane
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Abstract
Contrast agents for MRI can greatly improve the contrast in the image, making it easier to pinpoint 
the position of, for example, inflamed tissues or tumors. There is a need for novel contrast agents 
with better spatial resolution, higher sensitivity, fewer false positives and lower toxicity. As for all 
pharmaceuticals, it is important to thoroughly test the compound prior to clinical applications. 
The contrast agent IXG, currently under development by Spago Imaging AB, was analyzed in vitro 
for cellular uptake and toxicity. In order not to complicate future patents, a precursor was used. 
Viability analysis of HepG2, L929, RAW264.7 and Jurkat cells showed no apparent toxicity at 
concentrations above what is clinically relevant, while HUVEC cells were more affected. Cellular 
uptake was analyzed by ICP-AES and complemented with immunocytochemical staining. 
An internalization of IXGp was seen in RAW264.7 cells and possibly, but not confirmed in Jurkat 
cells, but only when the cells were incubated with high concentrations.  No uptake could be proven 
in HUVEC, HepG2 and L929 cells. The findings in this report can help in forming hypothesis on 
how IXG behaves in in vivo and may be useful for further developing the nanomaterial. 
Introduction
More than 10 million people around the globe were expected to be diagnosed with cancer in 20081. 
Factors contributing the most to cancer are unhealthy food, smoking and infections. Other causes of 
cancer include radiation, stress, lack of physical activity, genetic heritage and pollutants1. It is 
estimated that in 2014 about 1.5 million people in USA will be diagnosed with cancer and about 
600 000 will die within the year2. Breast cancer is the most common cancer form in American 
women and prostate cancer is the most common for men. Cancer in the lung and bronchus area is 
the second most common type, but it is the cancer form that claims most lives2. Reliable detection 
methods are important in order to be able to treat the disease in an early stage. Some methods for 
detection include CT, PET and MRI and methods for treatment are for example surgery, radiation- 
and chemotherapy3. Compared to two commonly used non-invasive imaging methods, CT and PET 
scans, radiation is not used in MRI and the spatial resolution of the image is still good4.
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Magnetic Resonance Imaging
MRI is based on the quantum mechanical spin and positive charge of protons, which turn them into 
tiny magnets. If an external magnetic field, denoted B0, is applied on a solution, a small excess of 
the proton spins will align with the B0 field, forming the so called NMV. Individual spins will be 
turning around B0 at a certain frequency (ω). This frequency falls within the RF range and short, 
external RF pulses can force a small excess of the spins to change direction and start to turn around 
in the transverse plane instead, 90° to the B0 field. The spins will start to relax and return to the 
longitudinal plane. The term used for the recovery process back to the longitudinal plane is called 
spin-lattice relaxation and the time constant for the process is denoted T1. The process of decay in 
the transverse plane is called spin-spin relaxation and the time constant for this process is called T2. 
In the T1 recovery process energy is transferred from the nuclei to the environment, while in the T2 
decay process, energy is exchanged between nuclei. The NMV is detected with a receiver coil 
placed in the transverse plane, which registers the voltage that is created when the NMV in the 
transverse plane moves across the coil. It is possible to create contrast in images of the body because
different tissues have different relaxation times and thus different signal intensities. For example, 
the molecular tumbling in water is much higher than in fat, and this makes the recovery of the NMV
in water less efficient, resulting in a longer T1.4 
If this natural differences in contrast is not enough for a good image, one can use so called MRI 
contrast agents which can either increase or decrease the relaxation times, significantly improving 
the contrast in the images. To reduce the toxicity and tumbling rates T1 enhancing agents can be 
bound to macromolecules or cheleated to organic ligands5. A water molecule that binds to the agent 
will tumble with it and be exposed to randomly oscillating magnetic fields. This stimulate to 
longitudinal relaxation and thereby shortens the T1. Water molecules bind and dissociate with the 
contrast agent, allowing the effect to be spread out in the solution5. The local magnetic fields of T2 
enhancing agents affect the relaxation processes of the protons in water molecules nearby, resulting 
in shorter spin-spin relaxation time (T2)6. Contrast agents are for example based on chelated 
gadolinium (Gd3+), iron (Fe3+), or manganese (Mn2+)4. 
Contrast Agents
Of all the MRI procedures done today, about 35 % include contrast agents7. There are two groups of 
contrast agents, the paramagnetic compounds that primarily reduce the T1, giving a brighter image, 
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and the super-paramagnetic nanoparticles, which shorten T2, resulting in a darker image. 
Gadolinium and manganese, belong to the first group while iron oxides fall into the second group. 
The main factors that determine how much a contrast agent can affect the relaxation rate are its size 
and chemical composition8. With its advantageous properties, the focus in this field has mainly been
on gadolinium complexes. The metal displays high para-magnetism due to its seven unpaired 
electrons, has long electronic relaxation time and form very stable complexes with for example the 
ligand polyaminopolycarboxylate7. However, patients who are injected with gadolinium have a risk 
of developing NSF and nephrogenic fibrosing dermopathy, especially if they already have an 
impaired renal function8. Manganese is one of the first paramagnetic agents evaluated in hepatic and
cardiac MRI, but the coordination number is 6, making it difficult to form very stable complexes 
with one or more water molecules7. 
By designing contrast agents in the nanorange size one can make use of the EPR effect to 
specifically target the agents to tumors. Nanoparticles used as contrast agents are often coated with 
different molecules to improve its functions and shield it from the immune system9.
The Enhanced Permeability and Retention Effect
Pharmacological molecules can be targeted to to tumors by the EPR effect. This effect happens 
because tumors that reaches sizes of 150-200 µm begin to stimulate the formation of new blood 
vessels to support their increasing demand of oxygen and nutrition10. The structure of these tumor 
blood vessels is rarely very good since they often lack a smooth muscle layer and consist of badly 
aligned and defective endothelial cells, resulting in unusual wide fenestrations10. The lymphatic 
drainage is ineffective in tumors, a factor that allows the particles to remain in the tumor for a 
longer time10. Therefore, the molecular- and fluid transportation will be abnormal within the tumor. 
Thus, by creating a nanomaterial of just the right size, it will have the potential to circulate in the 
blood until it reaches the tumor where it can exit the blood stream via the abnormal blood vessels 
and then remain in the tumor for a longer time. 
Ion-X-Gel
Since many of the commonly used contrast agents today may cause NSF and are prone to generate, 
there is a need for new types of contrast agents. Spago Imaging AB is currently developing a novel 
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nanosized contrast agent with potential for greater spatial resolution and fewer false positives and 
side effects. Their goal is to produce a cost effective product that makes it possible to locate soft 
tissue cancers at an earlier stage than currently possible, thereby lowering the suffering and 
treatment time for patients. One of the particle's advantages is that it can easily be customized. The 
surface can for example be treated in different ways and the size can be modified, allowing the 
particle to be directed at specific target tissues and having the desired cellular interaction. The core 
particle is a biocompatible nanomaterial called Ion-X-Gel, consisting of cross-linked, silicon based 
polymers with a PEGylated surface. By embedding paramagnetic manganese into the polymer 
framework the resulting relaxivity is six times better than the currently available gadolinium-based 
contrast agents11. The nanomaterial will be injected into the blood stream where it will circulate until
it reaches the leaky blood vessels of the tumor tissue where it will enter the tumor and accumulate 
via the EPR effect. To be able to publish this work without ruin future patents, experiments were 
done using a precursor of IXG, without manganese. 
Nanoparticle Coating
Nanoparticles can be coated with repeats of ethylene ether to make them less prone to interact with 
surrounding molecules and cells. The PEG units form a passive surface on the particles and reduce 
the risk of aggregation, which otherwise could lead to capillary occlusion and trapping the particles 
in for example the lungs and liver9. PEGylated nanoparticles are also better shielded from uptake via
the RES system, allowing them to remain in the circulation for a longer period, rather than being 
transported to the spleen and liver9. Charge interactions with proteins and small molecules are also 
reduced, while the solubility in buffer and serum is increased because of the hydrophilic properties 
of the PEG9. PEGylation is FDA approved for a large range of applications and often cheap9. 
Nanoparticle Size and Structure Influence Uptake
The size and surface functionalization of nanoparticles affect their rate of internalization in cells. 
Increasing size has been reported to both increase and decrease uptake. Doiron et al. (2011) showed 
that, in HUVEC cells, 20 nm polystyrene spheres were adhered and internalized 300 times more 
effective than 100 nm particles12. On the other hand, when the cells were grown in a 3D collagen 
hydrogel, larger particles up to 500 nm were internalized faster12. Another study on Jurkat and 
PANC1 cells using 10 – 100 nm gold particles revealed a higher cellular uptake with increasing 
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particle size13. The PANC1 cells were reported to internalize the particles more effective than 
Jurkat13.  SPIO particles of 20 – 150 nm has been seen to be taken up more effectively by human 
monocytes if the particles are larger and if functionalized with ionic carboxy groups, they were also 
taken up better than non-ionic particles14. Saito et al. (2012) reported that mouse macrophages 
(RAW264) cells internalized alkali-treated dextran magnetite more effectively than dextran 
magnetite coated with carboxymethyl15. A study showed that non-functionalized polyisoprene 
nanoparticles were taken up by Jurkat and HeLa cells more effectively compared to other polymeric 
particles16.  
The Current Study
It is important to evaluate and learn how medicals behave in a living organism. Any newly 
developed molecule or particle that is to be in contact with the human body must be thoroughly 
tested prior to clinical applications. In this project the interaction of IXGp with different cells has 
been studied with focus on internalization of the nanoparticles and their toxicity. The experiments 
were carried out in vitro as one of the first steps to forming hypothesis about how the particles might
behave in in vivo systems. The ideal IXG nanomaterial would have a very limited toxicity and 
would only be taken up by cells to a low degree, allowing it to stay in the blood stream for a longer 
time. Four immortalized cell lines, HepG2, Jurkat, L929 and RAW264.7, as well as the non-
immortalized HUVEC cell line were exposed to various concentrations of IXGp for 24 hours. 
CellTiter Blue fluorescence was used to determine the metabolic activity of the cells, as a 
measurement of viability. The amount IXGp taken up in the cells was determined by measuring the 
silicon content using ICP-AES and the experiments were complemented with immunocytochemical 
staining. SPIO particle were used as a positive control for nanoparticle uptake, as many cell types 
are known to internalize the particles14. Uptake of SPIO was analyzed with a NMR 60 µMz 
relaxometer and confirmed with Prussian Blue staining.
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Materials and Methods
Preparation of IXGp
PEGylated IXGp was isolated from a crude production batch made by Spago Imaging AB. The 
correct particle size was isolated by filtration as follows. The particles were first prefiltered through 
a 0.45 µm Rapid-Flow filter (Nalgene) and then through a 300 kDa laminar flow filter (Pall) 
together with a double volume of 150 mM NaCl. The permeate was again diluted with a double 
volume of 150 mM NaCl and was then filtered on a 10 kDa laminar flow filter (Pall). The retentate 
was collected and  filtered through a sterile 0.2 µm Supor membrane (Pall) to remove dust particles.
The particles were electrolyte balanced using a confidential method. The pH was adjusted to 7.4 
with 1 M NaOH and the osmolality was determined using a Vapor Pressure Osmometer (Wescor). 
The sizes of the crude and filtered particles were determined using HPLC (Chromtech) with a gel 
filtration column (Pharmacia) and an ELSD 2000 (Alltech). The IXGp concentrations was 
determined by measure the silicon content using ICP-AES. A chromogenic Limulus Amebocyte 
Lysate test (Lonza) was used by Spago Imaging AB to verify that endotoxins were not present. 
Unless otherwise stated, all IXGp particles used were electrolyte balanced.
Preparation of SPIO Particles
PEGylation of SPIO
Pure super-paramagnetic iron (II, III) oxide nanoparticles in aqueous solution with a size of 10-12 
nm (ABCR, Germany), in six different concentrations (0.9 - 2149 mM Fe) were incubated for 1-2 
days with 0.35 or 2.4 M PEG 1000 (Fluka, Germany) and were then diluted to a series of different 
concentrations (0.9-358 mM Fe) in distilled water. Non-PEGylated SPIO (naked SPIO) was used as 
controls. The solutions were sonicated for 20 min at 37 °C using a Ultrasonic Cleaning Bath 
(Branson) and were then filtered through a 0.2 µm Supor syringe filter (Pall). 
PEGylation was also done on 4.8 nm SPIO nanoparticles stored in toluene (Sigma-Aldrich) 
following the methods used by Ma et al17. SPIO and PEG 1000 were mixed together in 
dichloromethane, giving final concentrations of 8 mM Fe and 0.45 mM PEG 1000. The SPIO was 
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slowly diluted to 2 mM Fe in DMSO. Attempts to concentrate the particles were first done by 
centrifugation at 1610 x g for 2 minutes and then by washing with milli-Q water 8 times while 
placed on a strong magnet. 
Prior to DLS analysis (see section Stability of Nanoparticles), unattached PEG molecules were 
removed from the SPIO particles by spin filtration at 10 kDa (Amicon Ultra, Míllipore). The 
solutions were filtered 4 times at 12 000 x g for 10 min, discarding flow through. For SPIO 
PEGylated at 2.4 M PEG, surplus PEG was more difficult to remove since the solution was too 
viscous for filtration with a spin filter. Thus, the samples were diluted in water and centrifuged at 
920x g for 5 min to spin down the heavier particles, separating them from the lighter PEG units.  
The particles were then filtered with a centrifugal filter of 10 kDa (Amicon Ultra) at 5525 x g for 20
min. The retentate was washed 8 times with 4 ml water by centrifugation as above. Naked SPIO 
were filtered through a 0.2 µm Supor syringe filter (Pall). 
Coating of SPIO with APTMS
SPIO in aqueous solution was diluted to 215 mM Fe in 70% EtOH or MetOH and was sonicated in 
water bath for 1 hour at roughly 37 °C. APTMS (Aldrich) was added to a final concentration of 0.2 
or 0.4 %. The samples were sonicated for 2 hours and nitrogen gas was blown on the solutions for 
10 min to remove the alcohol. The particles were dried either overnight at 50 °C or for 2 hours at 50
°C and then at room temperature for three days. The particles were resuspended in distilled water to 
three different concentrations of Fe (54 - 430 mM), sonicated for 2 hours and filtered through a 0.2 
µm Supor syringe filter (Pall). The presence of APTMS on the SPIO particles was verified with 
ninhydrin staining (Sigma-Aldrich); using glass capillaries, APTMS coated SPIO was spotted on a 
filter paper and a ninhydrin solution of 1.4 M in 99.5 % EtOH was placed on top. Naked SPIO of 
197 mM Fe in 70% EtOH and 0.4% APTMS in 70% EtOH were used as controls. A purple color 
signifies the presence of APTMS as ninhydrin reacts with amines and forms a colored product.
Stability of Nanoparticles
PEGylated, APTMS coated and naked SPIO were diluted to 0.22-90, 0.25–72 and 0.2 - 120 mM Fe, 
respectively in distilled water, 0.9% NaCl, RPMI- and DMEM cell culture medium, all four 
solutions with and without 10% FBS supplementation. After incubation for two hours at room 
9
temperature, the solutions were visually examined for any signs of aggregation or changes in color. 
IXGp could not be tested in this way due to a similar diffraction index as water.
DLS analysis was done to see how the IXGp and SPIO particles behave in different solutions  
regarding size and particle aggregation. PEGylated and naked SPIO particles were diluted to 1 - 36 
and 1 - 7 mM Fe, respectively, in DMEM cell culture medium with 10% FBS, distilled water and 
PBS. IXGp solutions of 21 - 107 mM Si were filtered at 0.2 µm and measured in DMEM- and 
RPMI cell culture medium with 10% FBS, and in milli-Q water, 150 mM NaCl, and PBS.  DMEM 
and RPMI with and without 10% FBS, and distilled water were used as blanks. Non-electrolyte 
balanced IXGp were tested using the same parameters. 
ICP Analysis
The concentrations of Fe in PEGylated and naked SPIO, of Si and P in IXGp stock solutions, and of 
Fe and Si in cells treated with SPIO and IXGp, respectively, were determined by ICP-AES at the 
Plant Ecology laboratory, Lund University. Prior to analysis, SPIO solutions and cells exposed to 
SPIO were diluted in 6 M HCl, while cells incubated with IXGp were first diluted in 4 M KOH 
where after the pH was adjusted to roughly 12 using 6 M HNO3. The personnel at the ICP facility 
used 0.02 M HNO3 or 12 M HCl to further dilute the samples to appropriate concentrations.
Cell Cultures
Cell cultures were maintained in 75 cm2 flasks at 37 °C, 5% CO2, 95% humidity, and were 
subcultured about 2 times a week when reaching 80% confluency. HepG2 and L929 cell lines were 
grown in DMEM (HyClone) medium and Jurkat and RAW264.7 in RPMI 1640 (HyClone) medium.
Both media where supplemented with 10% FBS (HyClone) and penicillin-streptomycin solution (10
000 U penicillin/ml, 10 000 ug streptomycin/ml, HyClone). HUVEC cells were grown in Medium 
200 with Low Serum Growth Supplement (Life Technologies), 5 mg gentamicin/ml and 125 µg 
amphotericine B/ml (Life Technologies). Bürker cell counter were used to determine cell number.
Growth curves and toxicity tests were carried out in 96 well-plates with black or clear walls, by 
seeding 2000-10 000 cells in 90 µl/well. Nanoparticle uptake and staining tests were performed in 6 
well-plates by seeding 5x105 cells in 3.6 ml/well. After being seeded, the cells were allowed to settle
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for one day and were then treated with nanoparticles for 16-24 hours before being further analyzed. 
Cellular Growth Curves
Growth curves were established by seeding 2000 - 10 000 HepG2 and Jurkat cells in 90 µl/well in 
96 well plates. At 0, 20, 44, 68 and 92 hours after seeding, 10 µl CellTiter Blue (Promega) was 
added to 6 wells for each cell type and to 1 well with medium (blank). The fluorescence was 
measured 4 hours after addition of CellTiter Blue at Ex560 nm and Em590 nm using a fluorescence 
plate reader, FLUOstar Galaxy (BMG Labtechnologies). 
Total fluorescence as a function of cell density was determined by making dilutions series and 
seeding 781 - 105 Jurkat cells in 8 different concentrations in 90 µl/well to 6 wells/concentration and
measuring fluorescence 4 hours after the addition of CellTiter Blue. 
Toxicity of SPIO and IXGp
HepG2, Jurkat, RAW264.7, L929 and HUVEC cells were seeded at 5 000 or 10 000 cells in 90 
µl/well in 96 well plates with black or clear walls, incubated overnight and were then treated with 4 
- 7  different concentrations of naked SPIO (0.05-1.8 mM Fe) or 5 different concentrations of IXGp 
(0.5- 21 mM Si). Cells were also incubated with 5 mM Si (IXGp) that had not been electrolyte 
balanced. After 24 hours incubation with particles 10 µl CellTiter Blue (Promega) was added to the 
cells, and after another 4 hours the CellTiter Blue fluorescence was measured at Ex560 nm and 
Em590 nm using a FLUOstar Galaxy (BMG Labtechnologies). 
To see if potential toxicity was time dependent 1.8 mM Fe (naked SPIO) or 21 mM Si (IXGp) was 
added to cells 4 hours before measurement and compared to 24 hours incubation. Particles added 5 
minutes prior to measurement was used as a control to rule out any particle interference on already 
formed fluorescent product. Cell culture medium with particles, but without cells was used as a 
control and cells treated with only milli-Q water was used as another negative control.
Uptake of SPIO and IXGp
HepG2, Jurkat, RAW264.7, L929 and HUVEC were seeded at 5x105 cells in 3.6 ml/well in 6-well 
plates and incubated overnight. They were then treated with 0.036, 0.358 and 0.895 mM Fe (naked 
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SPIO) or 0.5, 2 and 21 mM Si (IXGp), in triplicate wells. Medium with particles but without cells 
was used as one type of negative control and cells treated with milli-Q water as another. Naked 
SPIO of 0.895 mM Fe was used as positive reference controls in IXGp uptake tests. After 24 hours 
incubation, the cells were washed 3 times with 4 ml medium or PBS. The cells were trypsinized 
with 400 µl trypsin. For HUVEC cells, 0.5-1 ml trypsin/EDTA (Gibco) was added for 1 min at room
temperature and 2 ml trypsin neutralizer (Gibco) was used to stop the trypsinization. All cells, 
except Jurkat, were resuspended in 4-6 ml medium and were transferred to test tubes. The non-
adherent Jurkat cells were instead pooled into tubes without trypsinization. The cells were 
centrifuged at 300 x g for 5 min and the pellets were washed 3 times with 5 ml PBS by vortexing 
briefly and centrifuging as above. 
One SPIO uptake trial on HepG2 cells were done by seeding 5x105 cells in 0.9 ml/well in 24-well 
plates. The final volume after addition of SPIO or H2O was 1 ml. Each well was washed 3 times 
with 200 µl PBS by pipetting and the cells were trypsinized with 200 µl trypsin. Medium of 0.5 ml 
was added to each well and 5 wells/concentration were pooled, giving triplicates of each 
concentration. The cells were centrifuged and washed as above, but using 3 ml PBS. 
In all uptake tests, nanoparticle adsorption controls were set up where the highest concentrations of 
SPIO or IXGp were added to the cells 10 minutes before the washing steps. The cell density in each 
triplicate sample was determined using a Bürker counting chamber. Cells treated with IXGp were 
pooled into 1 tube per concentration and frozen until ICP-AES analysis. 
Nuclear Magnetic Resonance Measurements
The T2 of cells treated with SPIO was measured the same day or a few days after the uptake tests, 
using a Minispec mq60 NMR broadband spectrometer (60 MHz, Bruker corporation) at 37 °C. The 
machine was set to measure 4 scans, sampling 200 data points, having a 20 sec recycle delay and a 
first pulse separator of 1 ms. A standard curve of T2 versus SPIO concentrations between 3.5 - 895 
µM Fe was measured in order to correlate NMR signal from cells incubated with SPIO to iron 
concentration.
Statistics
Mean values from collected data, where possible, were calculated and presented with standard 
12
deviations in graphs. Welch two sample t-test were used to test if data were significantly different. A
value below 0.05 were viewed as significant.
Prussian Blue Staining
HepG2 and RAW264.7 cells were seeded at 5x105 cells in 3.6 ml/well in 6-well plates, incubated 
overnight and then treated with 0.9 mM Fe (naked SPIO) in triplicate wells. Medium with particles 
but without cells was used as one type of negative control and cells treated with milli-Q water as 
another. After 24 hours, the cells were incubated with 0.5 ml 4% formaldehyde for 40 minutes at 
room temperature, air dried for 20-35 minutes and incubated with 0.5 ml working iron stain solution
(Accustain, Sigma-Aldrich) for 10 min at room temperature. Nanoparticle adsorption controls were 
set up where cells were treated with 0.9 mM Fe (naked SPIO) for 10 minutes before the washing 
and staining steps. The staining was done both with and without 0.5 ml Neutral Red counter staining
for 1 min at room temperature. The cells were washed 3 times with 2 ml PBS before and in-between
addition of each reagent, and once after Neutral Red counter staining. The stained cells were viewed
with a microscope.
Immunocytochemical Staining
HUVEC, RAW264.7, L929 and HepG2 cells were seeded at 5x105 cells in 3.6 ml/well in 6-well 
plates, incubated overnight and then treated with 0.5, 2 and 21 mM Si (IXGp). Medium with 
particles but without cells was used as one type of negative control and cells treated with milli-Q 
water as another. Before and in-between addition of the following solutions, the cells were washed 2
times with PBS for 3 minutes by shaking at 200 rpm. The HUVEC cells were never exposed to 
shaking as they easily detached. The cells were fixated with 1 ml 4% formaldehyde for 20 minutes 
or with 0.5-1 ml 5% glacial acetic acid in 95% EtOH for 3-7 min and then treated with 0.5-1 ml 3% 
Tween 20 (Sigma-aldrich) for 10 min. Cells incubated with 21 mM Si (IXGp) but not permeabilized
with Tween 20 were used as adherence controls. The cells were incubated with 0.5-1 ml 3% H2O2 in
PBS for 10-15 min and then with 1-1.5 ml 1-5% FBS in PBS for 1-1.5 hours. The cells were then 
incubated with 0.5-1 ml 1 µg/ml rabbit-anti PEG-B-47 (Abcam) for 2 hours and were then washed 
with 4 ml 1% FBS in PBS for 3 min. Cells incubated with 21 mM Si (IXGp) but not exposed to 
anti-PEG were used as negative controls. The cells were incubated with 1 ml 0.4 µg/ml goat anti-
rabbit IgG (H+L), conjugated with horseradish peroxidase (Pierce, Thermo Scientific) for 2 hours. 
The cells were washed with 1% FBS for 10 min and were then treated for 5-7 min with 1 ml DAB 
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substrate (Thermo Scientific) prepared according to manufacturer's instructions. The cells were 
washed 2 times with 4 ml PBS and were then viewed with a microscope. Nanoparticle adsorption 
controls were set up where cells were treated with 21 mM Si (IXGp) for 10 minutes before the 
washing and staining steps.
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Results and Discussion
Stability of SPIO
Five different concentrations of naked SPIO were incubated for 2 hours in different solutions and 
visually examined for aggregates and color changes. No signs of aggregation was seen when 
diluting naked SPIO to 0.2 – 14 mM Fe in DMEM- and RPMI cell culture medium supplemented 
with 10% FBS. This gave a first indication that naked SPIO was stable enough in the cell culture 
medium, even at an iron concentration 16 times higher than used in the uptake tests. In DMEM 
without FBS, a lot of SPIO aggregation was observed at 5.6 mM Fe. Naked SPIO at 120 mM Fe 
formed aggregates in all solutions, except water, with the most aggregation in DMEM. A high 
degree of aggregation was seen when PEGylated SPIO were diluted in DMEM without FBS to 0.7 
mM Fe, but very little aggregation was observed in DMEM supplemented with 10% FBS. No 
aggregates were seen in RPMI with or without FBS up to 9 mM Fe. PEGylation of SPIO in toluene 
did not work as the particles got stuck on the pipette.
SPIO treated with APTMS was rendered much more prone to aggregate compared to naked SPIO 
particles. In some cases aggregates were formed during the coating procedure and much of the iron 
was lost during filtration. Thus, even though the tests for the presence of APTMS using ninhydrin 
turned up positive, the method used for coating with APTMS did not work.
The notion that the PEGylation of SPIO did not work was confirmed with DLS. According to the 
manufacturer the SPIO particles should have a size of 10 - 12 nm, but as seen in figure 1, 
PEGtreated SPIO particles had a mean size of about 40 - 70 nm when diluted in water, 70 and 260 
nm in PBS and 72 and 78 nm in DMEM (10% FBS). The two highest concentrations of SPIO, 10 
and 40 mM Fe are estimates because the exact concentrations is not known since those solutions 
come from two different SPIO sediments of the same solution. It is unexpected that the lowest 
concentration of the two SPIO solutions in PBS have a much higher mean value, but seeing as the 
standard deviations is larger than the actual mean value it means that there are a large range of 
different sizes detected by the DLS apparatus which could mean that for example dust particles have
entered the solution. 
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Figure 1: DLS measurement of PEGtreated SPIO particles in water, PBS and DMEM (10% serum). 
Data is presented as mean values with standard deviations. The two highest concentrations here are 
estimates since those solutions come from two different SPIO sediments of the same solution.
Figure 2 show DLS analysis of 1.9 and 9.6 mM Fe (naked SPIO) in water and 9.6 mM Fe (naked 
SPIO) in PBS and DMEM (10% FBS). In water the sizes are about 40 and 380 nm, and in PBS and 
DMEM (10% FBS) around 170 and 230 nm, respectively. The mean sizes of naked SPIO particles 
are generally higher compared to PEGtreated SPIO particles, but the aggregation is till high in 
PEGtreated particles as well. Since the coating of the SPIO particles did not work and since it was 
not the main goal in this project and time was limited naked SPIO particles were instead used in the 
uptake tests as no aggregates were seen during visually examinations of SPIO in cell culture 
medium supplemented with 10% FBS.
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Figure 2: DLS measurement of naked SPIO particles in water, PBS and DMEM (10% serum). Data is 
presented as mean values with standard deviations.
The methods for PEGylation and APTMS coating were based on a previous project work at Spago 
Imaging AB, where magnetic iron (II, III) oxide (ABCR, Germany) in aqueous solution was 
successfully APTMS coated and PEGylated with PEG100018. In the present project, the same type 
of SPIO particle was used, but for some reason the coating did not work.
Stability of IXGp
Using HPLC (Chromtech) with a gel filtration column and an ELSD 2000 (Alltech) the size of the 
crude and electrolyte balanced IXGp particles was roughly determined to be between 4 and 6.5 nm 
(the sizes of the control proteins myoglobin and albumin) in an ammonium carbonate buffer of pH 
7.4. There was no detectable difference in size if the particles were electrolyte balanced or not. 
DLS measurements on non-electrolyte balanced IXGp diluted to 21 - 107 mM Si in water and NaCl 
and undiluted particles, 215 mM Si, can be seen in figure 3. The undiluted IXGp particles showed a 
size of 2.8 nm which decreased to roughly 2.3 nm in water, a phenomenon that has been seen before
at Spago Imaging AB and is believed to be a combination of the particles being relative small and 
having a refractive index similar to H2O, which make them difficult to detect when diluted. The 
particle sizes instead increased to 4.0 - 4.9 nm when diluted in NaCl which has also been seen 
before in reports from Spago Imaging AB. The larger size seen with the HPLC compared to the DLS
on undiluted and water diluted particles could be explained by the ammonium carbonate buffer 
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containing ions, as ions could bind in the structure and cause an increase in size, similar to the 
increase in size of the particles diluted in PBS and NaCl solutions. 
Figure 3: DLS measurement on various concentrations of non-electrolyte balanced IXGp particles 
in water and NaCl. Data is presented as mean values with standard deviations.  
In figure 4 DLS measurements on electrolyte balanced IXGp particles, adjusted to pH 7.4 can be 
seen. The electrolyte balanced particle are in general larger, 7.1 nm as undiluted and decrease down 
to 4.9 nm when diluted in water. The size is marginally lowered to 6.9 in PBS while in RPMI (10% 
FBS) and DMEM (10% FBS) the sizes are larger, 7.8 and 10 nm, respectively. The larger size of the
electrolyte balanced and pH adjusted particle could again be due to exposure to ions, for example 
during the pH adjustment. Exposure to more ions in the PBS solutions would not increase the size 
further if the particles were already saturated with ions. Seeing as RPMI (10% FBS) and DMEM 
(10% FBS) alone show sizes of 8.3 and 7.8, the apparent increase in size of IXGp when diluted in 
cell culture medium supplemented with serum could be an artifact caused by detection of the serum 
proteins. Over all, these results strongly suggests that the IXGp particles are stable in water, NaCl 
and cell culture medium. 
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Figure 4: DLS measurement on various concentrations of electrolyte balanced IXGp particles 
adjusted to pH 7.4. The particles were measured in water, PBS, DMEM (10% FBS) and RPMI 
(10% FBS). Data is presented as mean values with standard deviations.
The osmolality of the IXGp particles were determined to 820 mosmol/kg H2O which is higher than 
the physiological value of about 290 mosmol/kg H2O19, but osmolality of up to 800 mosmol/kg H2O
is tolerated for intravenous injections of smaller volumes19. To the author's knowledge, there is no 
easy way of lowering the osmolality and therefore it was decided to continue using these particles. 
HepG2 and Jurkat Cellular Growth Curves
The fluorescence seen when cells are treated with CellTiter Blue comes from the compound 
resorufin. Actively metabolizing cells convert the molecule resazurin, in the CellTiter Blue 
substrate, into resorufin. The total metabolic capacity determines the amount resorufin formed and 
thus, the fluorescent signal. In the cellular growth curves the increased signal over time has been 
interpreted as an increase in cell number, with the assumption that the cells had similar metabolic 
activity during the time interval. Figure 5 shows relative fluorescence of cells 4 to 96 hours after 
seeding 2000 Jurkat cells and 5 000 or 10 000 HepG2 cells. It appears that HepG2 cells immediately
fall into a steady doubling time (assuming constant metabolic activity for each cell) which start to 
decrease a little after 24 hours if 10 000 cells were seeded. When seeding 2000 Jurkat cells, the 
doubling time is markedly slower, probably due to low cell concentrations which would lead to low 
contact based cell signaling, slowing down growth. The differences between the two HepG2 curves 
are significant for all time points except after 72 hours. Oddly, when seeding 5000 HepG2 cells, a 
plateau phase is reached after 72 hours, while the cells continue to grow if 10 000 cells were seeded 
19
initially. On the other hand, the fact that the two growth curves with HepG2 cells appear to reach 
similar cell densities after 72 hours suggests that the initial higher cell number of 10 000 cells 
begins to hinder the growth as cells likely are reaching a high confluency. 
Figure 5: Growth curves of Jurkat and HepG2 cells presented as mean relative fluorescence per hour 
+/- standard deviation. The initial cell number can be seen in the legend. Cells were cultured in 90 
µl/well in 96-well plates, 6 replicates. The starts indicate a significant (p<0.05) difference between the 
three graphs at respectively time interval.
During viability measurements on cells treated with SPIO or IXGp, 5000 or 10 000 cells were 
seeded in 96-well plates. Thus, these results suggests that HepG2 and presumably the other cell 
lines as well, were in growth phase during the viability tests (24-48 hours after initial seeding), since
5000 or 10 000 cells were seeded in 96-well plates for the viability tests. On the other hand, this 
data is more difficult to apply to the uptake tests because the cells were seeded in 6-well plates since
only 96-well plates could be analyzed in the available fluorescence plate reader. The cells in the 
uptake tests were seeded at a concentration 6.25 times higher than the Jurkat cells in the growth 
curve and it looked like the cells had grown well when observed in a microscope. Since the growth 
curves were only a reference to verify at what growth phases the cells were in during the uptake test,
growth curves were only created for two of the five cell types. 
To determine how well the number of cells correlate with relative fluorescence, dilution series of 
Jurkat were done (figure 1, appendix 1). The number of Jurkat cells versus fluorescence gives a 
linear relationship up to 1800 relative fluorescence.
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Toxicity of SPIO
The metabolic activity of cells treated with naked SPIO is presented in figure 6 as percent 
fluorescence compared to control cells not treated with SPIO. Up to 1.8 mM Fe (naked SPIO) 
appear to have no negative effect on L929 and HepG2 cells, but instead increase the metabolic 
activity almost up to 120% of control. Jurkat cells instead show a slight, but significant decrease in 
fluorescence after 0.9 mM Fe, which then increased again at 1.8 mM Fe. The RAW264.7 cells show
a drastic increased in florescence signal up to 160% of control at 0.9 mM Fe (naked SPIO) and then 
decrease slightly at 1.8 mM, but there is no significant difference between the two data points. The 
HUVEC cells here are very sensitive to the SPIO particles with a dramatic decrease in fluorescence 
signal. 
Figure 6: Viability of cells incubated with various concentrations of SPIO over 24 hours, presented as
mean percent of control +/- standard deviation. Control cells for each cell line were cells treated with 
only H20. Cells were seeded in 90 µl//well in 96-well plates, 3 replicates. CellTiter Blue was added 4 
hours before measurements. The stars show a significant difference (*: p<0.05, **: p<0.01) compared
to control. A plus sign indicates a significant (+: p<0.05, ++:p<0.01) difference between two data 
points. 
Figure 7 shows metabolic activity in percent of control for cells treated with 1.8 mM Fe (naked 
SPIO) for 5 minutes, 4 hours and 24 hours. The fluorescence signals are significantly increased for 
RAW264.7 and L929 cells compared to control, at all data points. It should be noted that only 1-2 
replicates were made for Jurkat and HepG2 cells incubated for 5 minutes and 4 hours and thus 
neither standard deviation nor a significant value can be calculated, however these two cells types 
show a fluorescent signal closer to the control value than the other cell lines, thus appear to be less 
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affected by SPIO. The HUVEC cells here are very sensitive to the SPIO particles already after 5 
minutes. 
Figure 7: CellTiter Blue viability of cells incubated with 1.8 mM Fe (SPIO) for 5 minutes, 4 hours and 
24 hours, presented as mean percentage of control +/- standard deviation. Control cells for each cell 
line were cells treated with only H20. Cells were seeded in 90 µl//well in 96-well plates, 3 replicates. 
CellTiter Blue was added 4 hours before measurements. Note that there is no standard deviations for 
HepG2 and Jurkat cells incubated with SPIO for 5 minutes and 4 hours as only 1-2 replicates were 
possible to create. The stars show a significant difference (*: p<0.05, **: p<0.01) compared to control.
A plus sign indicates a significant (+: p<0.05, ++:p<0.01) difference between two data points. 
That the signal increase in RAW264.7 and L929 cells already after 5 minutes suggests that the SPIO
particles somehow might influence the signal as 5 minutes should not be enough time to trigger an 
increase in metabolic activity. That the fluorescence signals in general are increased already after 5 
minutes and as highest after 4 hours could mean that, in addition to slightly in some way enhance 
the signal, the SPIO particles also trigger an increased metabolic activity in the cells. When the cells
have adapted to the presence of the particles, the metabolic activity could perhaps decreases a little, 
but remains elevated as seen after 24 hours.
In a previous project work at Spago Imaging AB, CellTiter Blue viability was measured on HepG2 
cells incubated with PEGylated SPIO particles at the same concentrations as tested here18. An 
increase in signal was seen for lower concentrations, but not as great as here, suggesting that the 
PEGylated particles might interfere less with the signal and/or do not trigger an increased metabolic 
activity to the same extent. Olsson (2013) also reported HepG2 cells with a metabolic activity above
80% of control after 24 hours incubation with 1.8 mM Fe18, which suggest that there could be a 
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negative effect on metabolic activity, but this is not seen on HepG2 cells in this report. 
During the SPIO uptake tests, HepG2, L929, Jurkat and RAW264.7 cells, incubated with 0 - 0.9 
mM Fe (naked SPIO) for 24 hours, were counted and the cell numbers were similar for each SPIO 
concentration, within each cell line (data not shown). This confirms that SPIO up to 0.9 mM is well 
tolerated. SPIO uptake tests were never done on HUVEC cells and they were never counted, but 
SPIO were used as reference in IXGp uptake test where almost all HUVEC cells had detached from 
the bottom of the wells after 24 hours incubation with 0.9 mM Fe (naked SPIO).
In conclusion, up to 1.8 mM Fe (naked SPIO) seems to be well tolerated by L929, HepG2, 
RAW264.7 and Jurkat cells and the metabolic activity might even increase. HUVEC cells, on the 
other hand, reacted strongly to 0.9 mM Fe by a decrease in metabolic activity down to 9% of control
and detachment from the bottom of the wells. These data indicates that SPIO might be used as a 
reference particle for four of the cell lines. The downside is the toxicity of SPIO particles on 
HUVEC cells. The HUVEC cell line is especially relevant in this study as it is a human, non-
immortalized endothelial cell line and thus the most representative to an in vivo situation in humans.
Furthermore, IXGp will be in direct contact to endothelial cells while circulating in the blood. It is 
therefore unfortunate that SPIO particles could not be used as a reference particle for cellular uptake
in HUVEC cells. Perhaps, the HUVEC cells used in this report may not have been in a good state, 
as they were generally more difficult to handle, for example even untreated cells loosened from the 
wells during washing steps. The cells used here had been bought, gone through a few population 
doubling times and then frozen down again. In future projects it would be advisable to directly use 
newly bought HUVEC cells.
Toxicity of IXGp
The metabolic activity of cells treated with IXGp at 0 - 21 mM Si for 24 hours can be seen in figure
8. Up to 21 mM Si (IXGp) has no significant effect on L929, RAW264.7 and Jurkat cells. HepG2 
cells treated with 1.34, 5.37 and 10.74 mM Si (IXGp) show a significant increase in fluorescence 
signal, suggesting an elevated metabolic activity. The signal then goes below 100% of control at 21 
mM Si (IXGp), but this is not significant. The metabolic activity of HepG2 cells at 21 mM is only 
76% compared to the highest fluorescence level seen at 2.7 mM, suggesting that HepG2 cells might 
be affected. HUVEC cells show a decrease in overall metabolic activity already at 5 mM Si and 
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continue do decrease to 75% of control at 21 mM Si. 
Figure 8: CellTiter Blue viability measurements of cells treated with various concentrations of IXGp 
for 24 hours, presented as mean percent of control +/- standard deviation. Control cells for each cell 
line were cells treated with only H20. Cells were seeded in 90 µl//well in 96-well plates, 3 replicates. 
CellTiter Blue was added 4 hours before measurements. The stars show a significant difference (*: 
p<0.05, **: p<0.01) compared to control. A plus sign indicates a significant (+: p<0.05, ++:p<0.01) 
difference between two data points. 
Previous work by Olsson (2013) investigated HepG2 cells and reported an increased CellTiter Blue 
fluorescence up to roughly 110% of control when the cells were treated with <5 mM Si (IXGp) and 
and the signal then went down to roughly 65 - 90% at 28 mM Si18. This is in agreement with the 
data reported here, but the HepG2 data in this report is shifted upwards a few percent. 
In figure 9, cells incubated with 21 mM Si (IXGp) for 5 minutes, 4 hours and 24 hours can be seen. 
Only HepG2 cells show a significant increase in fluorescence after 5 minutes and 4 hours. HUVEC 
cells were significantly affected at all data points. Even if not significant in all cases, RAW264.7, 
HepG2 and Jurkat cells show an increase in signal after 4 hours incubation with IXGp and a lower 
value after 24 hours incubation which, similar to SPIO treatment, would suggest that an increase in 
metabolic activity has been triggered in the cells after 4 hours which then decrease after 24 hours 
when the cells have adapted to the particles or alternatively start to be negatively affected. The 
increase in fluorescence for HepG2 cells after 5 minutes suggest that IXGp also might influence the 
signal somehow as 5 minutes probably is not enough time for the cells to increase the metabolic 
activity notably. 
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Figure 9: CellTiter Blue viability of cells incubated with 21 mM Si (IXGp) for 5 minutes, 4 hours and 
24 hours, presented as mean percent of control +/- standard deviation. Control cells for each cell line 
were cells treated with only H20. Cells were seeded in 90 µl//well in 96-well plates, 3 replicates. 
CellTiter Blue was added 4 hours before measurements. The stars show a significant difference (*: 
p<0.05, **: p<0.01) compared to control. A plus sign indicates a significant (+: p<0.05, ++:p<0.01) 
difference between two data points. 
During the IXGp uptake tests, the cells were counted and in one test, HepG2, RAW264.7 and L929 
cells showed similar numbers of cells when treated with either H2O or 21 mM Si (IXGp) for 24 
hours. In another IXGp uptake test, the numbers were much lower compared to control, only 74, 71,
67 and 81% for HepG2, RAW264.7, L929 and Jurkat cells, respectively, when incubated with 21 
mM Si (IXGp) for 24 hours. HUVEC on the other hand was very difficult to handle and many cells 
were lost, even control cells. Consequently, two tests resulted in 2 and 6 times as many cells after 
treatment with 21 mM Si compared to control. Therefore, the counted HUVEC cell numbers can not
be compared to the CellTiter Blue viability tests (figure 8 and 9) as cells were likely lost due to the 
washing methods, not because of IXGp effects. The decrease in cell number with higher 
concentrations IXGp seen for the other four cell types would suggests a negative effect on the cells, 
but since this was not seen in all tests a negative effect can not be proven.
In conclusion, these cell lines are resistant to IXGp concentrations that are higher than clinical 
relevant concentrations (exact concentration is confidential), with L929, RAW264.7, Jurkat and 
HepG2 cells showing no significantly negative effect at 21 mM Si, even if the fluorescence signal 
do go down below 100% of control for Jurkat and HepG2. The HUVEC cells on the other hand 
decrease in metabolic activity down to 75% at 21 mM (IXGp).  
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The cells were also incubated with 5 mM non-electrolyte balanced IXGp particles to test if it had a 
greater effect on the viability. Cells treated with non-electrolyte balanced IXGp did indeed show a 
lower fluorescence signal (data not shown) compared to electrolyte balanced IXGp of the same 
concentration. Jurkat and RAW264.7 cells were considerably more affected by the non-electrolyte 
balanced nanomaterial with 53 and 41% metabolic activity compared to control, respectively. Jurkat
cells grow in suspension and RAW264.7 cells grow partly in suspension, while the other cell lines 
are adherent. This signifies the importance of electrolyte balancing the final IXGp particle.  
Uptake of SPIO Nanoparticles 
The correlation between SPIO concentrations and T2 was determined with a NMR 60 µHz 
relaxometer (data not shown). The results was then used to calculate iron concentrations based on 
the T2 values from the SPIO uptake tests on HepG2, Jurkat, L929 and RAW264.7. Figure 10 shows 
uptake of naked SPIO as nmol Fe/million cells. HepG2 show no significant uptake of SPIO particles
while Jurkat, L929 and RAW264.7 show significant uptake at all concentrations but the lowest, 
when comparing to background values of untreated cells. RAW264.7 and L929 cells show a 
significant higher uptake when incubated with 0.9 mM Fe (naked SPIO) for 24 hours compared to 
only 10 minutes, implying that the uptake might be due to internalization. If the uptake were due to 
adsorption alone, uptake after 24 hour and 10 minutes would be expected to be equal since an 
adsorption process is reasoned to be saturated much faster than an internalization. Because the 
uptake after 24 hour and 10 minutes is not significantly different in Jurkat cells, adsorption rather 
than internalization might have occurred in these cells. The uptake at 0.9 mM Fe after 24 hours is 
also lower in Jurkat compared to RAW264.7 and L9292 while the uptake after 10 minutes at 0.9 
mM Fe are comparably higher in Jurkat than the other three cell lines.
Over all, the trend is that the uptake increases with increasing concentration and incubation times. 
The rat macrophage cells, RAW264.7 show a markedly greater uptake capacity compared to the 
other cell lines. If the internalization requires energy, this could explain why a greater metabolic 
activity was reported for RAW264.7 cells incubated with SPIO (figure 6). The RAW264.7 cells with
a cell density of roughly 2 million cells/ml might be close to saturation when incubated with 0.04 
mM Fe for 24 hours as there is even a small decrease in uptake when incubated with 0.9 mM Fe 
(figure 10). 
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Figure 10: Uptake of SPIO nanoparticles in different cells, presented as mean nmol Fe/million cells +/-
standard deviation. Cells were incubated with various concentrations of SPIO for 24 hours or 10 
minutes. Cells were seeded in 3.6 ml/well in 6-well plates, 3 replicates. The stars show a significant 
difference (*: p<0.05, **: p<0.01) compared to control. A plus sign indicates a significant (+: p<0.05, 
++:p<0.01) difference between two data points. 
In a previous study, HepG2 and MDA-MB-231 cells were shown not to take up any particles after 
being incubated with 0.9 mM PEGylated SPIO particles for 10 minutes18. After 24 hours incubation,
the HepG2 cells took up almost 20, 40 and 110 nmol SPIO/million cells18. This shows that 
PEGylated SPIO do not adhere to the cell membrane after 10 minutes and that they are internalized 
up to 200 times more effectively after 24 hours incubation. 
SPIO uptake was also done on HepG2 cells seeded in 24-well plates instead of 6-well plates, using 
SPIO particles treated with PEG (figure 2, appendix 1). Note that the PEG treated SPIO particles 
behaved in the same way as naked SPIO particles (see section Stability of IXGp and SPIO particles)
and a successful PEGylation could not be confirmed. HepG2 cells seeded in 24-well plates 
compared to 6-well plates appear to take up 4 times as much SPIO, when incubated with 0.9 mM Fe
(PEGtreated SPIO) for 24 hours. Furthermore, there is hardly any difference in SPIO uptake 
between 10 minutes and 24 hours for HepG2 cells seeded in 24-well plates. However, the uptake 
test on HepG2 cells using 24-well plates were the first particle uptake test to be performed and the 
method for concentrating the cells was suboptimal with large variations making the data less 
reliable. Roughly only 10% of the total volume cell suspension in each test tube was taken to 
measure T2. The actual number of cells measured with the NMR relaxometer could in fact have 
been higher than expected due to difficulties in mixing of the cells, which would explain the higher 
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values that were calculated. It can also be noted that the background values of the HepG2 cells 
seeded in 24-well plates were roughly 2 nmol Fe/million cells while it was only about 0.5 nmol 
Fe/million cells when seeded in 6-well plates (similar to the background values for the other cell 
types). The initial number of cells and SPIO concentration was the same for both types of wells, but 
the volume medium added to the wells in the 6-well plates was 4 times larger. Thus, each cell 
seeded in 6-well plates was exposed to up to four times as many SPIO particles, assuming equal cell
doubling times. Cell counting during harvest revealed that the HepG2 cells seeded in 24-well plates 
had grown faster as there were only roughly 1.5 times more HepG2 cells in the 6-well plates. Since 
the HepG2 cells grown in 6-well plates were exposed to a higher number of SPIO particles/cell, a 
higher uptake is expected, but this was not the case. On the other hand, the cells seeded in 24-well 
plates grew faster and were perhaps more active and prone to internalize SPIO particles. 
Alternatively, the PEGylation could have worked to some degree, facilitating uptake, but this is 
contradicted by the higher uptake seen after 10 minutes. 
During the IXGp uptake tests, cells were also incubated with 0.9 mM Fe (naked SPIO) for 24 hours 
as a positive reference. Jurkat, L929 and HepG2 cells took up 1.3, 1.6 and 2.0 nmol Fe/million cells,
respectively, while RAW264.7 took up almost 15 nmol Fe/million cell. The uptake by L929 and 
Jurkat cells is similar to the data in figure 10, while RAW264.7 and HepG2 cells took up roughly 4 
times more SPIO compared to previous trial (figure 10). Note that no SPIO background control 
were done as these tests were only intended as reference for IXGp uptake. A second IXGp uptake 
test was done on L929, HepG2 and RAW264.7 cells and the SPIO taken up here was 3.4 nmol 
Fe/million cells for both HepG2 and L292 and as high as 149 nmol Fe/million cell for RAW264.7. 
The method for concentrating these cells were more properly done and almost 100% of the cell 
suspension volume was analyzed, giving a more reliable result. The extremely high value seen for 
RAW264.7 cells, almost 40 times higher than seen in figure 10, is most likely an artifact, but further
tests would be needed to confirm this. It can be mentioned that a second IXGp uptake test was also 
done on Jurkat cells, but was abandoned due to an extremely low cell number and thus, the SPIO 
uptake was never analyzed. 
Percent mol iron taken up is presented in figure 3, appendix 1. The percentage uptake decreases 
with increasing incubation concentrations. This implies that the cells reach some level of saturation 
and even though they take up more mol iron when incubated with increasing concentrations SPIO, 
the increased concentrations of SPIO added is much higher than the resulting increase in uptake. 
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In conclusion, the methods used here for testing uptake of nanoparticles in cells work and the cell 
lines HepG2, Jurkat, L929 and RAW264.7 have a capacity to take up nanoparticles, with the 
RAW264.7 cells being more effective than the other cells. Furthermore, the uptake of SPIO is  
concentration and time dependent. Internalization of SPIO in HepG2 and Jurkat cells can not be 
confirmed so far, while L929 and RAW264.7 cells appear to internalize the particles. 
Uptake of IXGp Nanoparticles
Ideally, no cell lines should internalize the IXGp particles since they are intended to circulate in the 
blood stream and target tumor tissue via the EPR effect. Uptake of IXGp in HepG2, Jurkat, L929, 
RAW264.7 and HUVEC cell lines is presented in figure 11, as nmol Si/million cells. Data was 
collected from one uptake test per cell type with the exception of HUVEC cells which were pooled 
from two uptake tests due to low cell numbers. Note that the HUVEC cells show an artifact H2O 
control value of 350 nmol Si/million cells. It should also be said that analysis of silicon 
concentration has been difficult in this experiment with large variations and unexpectedly high 
negative control values as well as some low values in spiked samples. Any contact with glass is a 
potential source of silicon contamination and there is also a risk of silicon precipitation when the pH
falls too low, making it difficult to detect the aggregated Si particles. Since the pH needs to be low 
during measurement, this presents a potential problem. Therefore another element or radio labeling 
would be advisable to use as as a tracer in future continuations on this project. 
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Figure 11: Uptake of IXGp in various cell lines presented as mean nmol Si/million cells. The cells 
were incubated with different concentrations of IXGp for 24 hours or 10 minutes, as depicted in the 
legend. Cells were seeded in 3.6 ml/well in 6-well plates. 3 replicates were pooled into 1 sample due 
to high costs, thus no standard deviations could be calculated.
In figure 11, Jurkat and RAW264.7 cells show a similar pattern with much higher uptake when 
incubated with 21 mM Si (IXGp) for 24 hours while the uptake at the other concentration is similar 
to respectively background values. All values, including negative control, appear to have been 
shifted upwards for RAW264.7 comparing Jurkat. That the uptake after 21 mM Si (IXGp) treatment
for 10 minutes is similar to negative control and that the uptake after 24 hours is much higher 
suggests that there could be an internalization in Jurkat and RAW264.7 cells. The data could again 
have been slightly shifted upwards for HepG2 cells where again 21 mM Si after 24 hours show the 
highest value while the other incubation concentrations are similar to negative control. Though, in 
HepG2 the uptake is also very high already at 0.5 mM Si while it becomes lower again at 2 mM Si. 
Thus this makes it more difficult to trust the data in HepG2 since any of the three middle data points
might be an artifact. If the data at 0.5 mM Si is an artifact, the pattern would be the same as Jurkat 
and RAW264.7 and an internalization might have occurred. No uptake or internalization can be 
concluded in L929 cells as the adsorption control with cells treated for 10 minutes are higher than 
negative control and value for 0.5 mM Si is much higher than all other data points. Any uptake or 
internalization of particles can not be seen in HUVEC cells either, especially with the extremely 
high water control of 350 nmol Si/million cells, making the data unreliable.  
In conclusion, no IXGp internalization can be determined in HepG2, L929 and HUVEC cells, while
RAW264.7 and Jurkat cells seem to internalize particles, but only at a concentration that is higher 
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than the intended clinical concentration (exact concentration is confidential). Olsson (2013) reported
a low IXGp uptake in HepG2 cells after 24 hours incubation18. HepG2 cells incubated with 15 mM 
Si took up roughly 4 nmol Si/million cells18, which is 3 times lower than the highest uptake seen 
here. Thus, cellular uptake of IXGp it likely low.
Figure 4, appendix 1 shows three other tests with IXGp in HepG2, L929 and RAW264.7 where the 
uptake values are much lower. HepG2 cells treated with 0.5 mM Si (IXGp) for 24 hours show an 
uptake of 15 nmol Si/million cell which looks like an outlier and HepG2 also generated an 
extremely high and unexpected value, 75 nmol Si/million cell, for the negative H2O control. 
However, too much focus should not be aimed at these three last tests with HepG2, L929 and 
RAW264.7, as they were left for a few days before being analyzed at the ICP-AES facility. During 
this time the Si particles could have formed precipitates if the pH fell too low during the 
preparations. There were also some unexpected results from control samples analyzed without cells. 
A sample spiked with 0.3 mM Si only showed a concentration of 2.4 µM Si and a control containing
only H2O and KOH had a value of 1.9 µM Si, a similar value to cells treated with IXGp. 
The percentage mol Si taken up compared to incubated mol is presented in figure 5, appendix 1 and 
reveal the same trend seen in the uptake test with SPIO, that the percentage is highest when 
incubating the cells with the lowest concentration nanoparticles and then quickly falls as the cells 
are incubated with higher concentrations and for shorter times. 
Prussian Blue Staining of SPIO
As a qualitative analysis for SPIO uptake the particles in RAW264.7 and HepG2 cells were stained 
with Prussian Blue, a dye that reacts with iron to give a blue color. Figure 12 shows Prussian Blue 
stained naked SPIO participles in HepG2 and RAW264.7 cells incubated with 0.9 mM Fe for 10 
minutes and 24 hours. Negative controls are also pictured. Blue coloration can be seen in HepG2 
cells incubated with 0.9 mM Fe for 24 hours (figure 12a) and it looks like the stained SPIO particles
are inside the cells, suggesting that the SPIO particles have been internalized. HepG2 cells 
incubated with 0.9 mM Fe for 10 minutes (figure 12b) show only a few cells with blue coloration. 
The particles appear to be inside the cells here as well, but a bit more closer to the cell membranes. 
RAW264.7 cells incubated with 0.9 mM over 24 hours (figure 12d) are almost completely black 
with some blue coloration, confirming the SPIO uptake data (figure 10) where RAW264.7 cell are 
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superior in uptake capacity. When incubated for 10 minutes with 0.9 mM Fe (figure 12e) many 
RAW264.7 cells show faint blue coloration inside but close to the cell membranes, suggesting that 
some SPIO particle have adhered and/or been internalized after 10 minutes. No blue coloration can 
be seen when the cells were incubated with H2O (figure 12c and f). 
Another Prussian Blue staining test was done were the RAW264.7 and HepG2 cells were counter 
stained with Neutral Red, but the counter staining made it difficult to see the blue coloration from 
the Prussian Blue dye. A clear uptake could still be seen for RAW264.7 cells incubated with 0.9 mM
Fe (naked SPIO) over 24 hours (data not shown). 
Thus, the Prussian Blue staining of naked SPIO particles confirm that SPIO particles are 
internalized in RAW264.7 to a great extent as seen in figure 10. The staining also conclude that the 
HepG2 cells do internalize SPIO particles, which could not be confirmed in figure 10 but was 
hinted when SPIO was used as a positive control during the IXGp uptake tests (as described in the 
section: Uptake of SPIO Nanoparticles). The internalization of SPIO in HepG2 and RAW264.7 cells
are time dependent. 
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Figure 12: Prussian Blue staining of naked SPIO in HepG2 and RAW264.7 cells. a: HepG2 cells incubated 
with 0.9 mM Fe (SPIO) for 24 hours. b:  HepG2 cells incubated with 0.9 mM SPIO for 10 minutes. c:  
HepG2 cells incubated with H2O. d: RAW264.7 cells incubated with 0.9 mM SPIO for 24 hours. e:  
RAW264.7 cells incubated with 0.9 mM SPIO for 10 minutes. f:  RAW264.7 cells incubated with H2O. 
Immunocytochemical Staining of IXGp
An immunocytochemical staining was done as a qualitative test for IXGp uptake. Cells incubated 
with IXGp were fixated and IXGp was stained using a system with DAB, anti-PEG antibodies and 
horseradish peroxidase. The peroxidase produces a brown color in contact with DAB. The more 
IXGp particles that have been taken up, the more anti-PEG antibodies can bind to the PEG on the 
IXGp particles and thus more horseradish peroxidase will be present to transform DAB, giving a 
stronger brown color. Figure 13 shows RAW264.7, L929 and HUVEC cells incubated with 0, 0.5, 2 
and 21 mM Si (IXGp) for 24 hours. It looks like there is more brown coloration when the cells are 
incubated with 21 mM Si over 24 hours (figure 13j-l) compared to H2O controls (figure 13a-c), 
suggesting that some IXGp particles are taken up. It should be said that the HUVEC cells were over 
all more difficult to handle in this project. Not many HUVEC cells were left after 
immunocytochemical staining and washing and it was especially difficult to see any cells in the 
negative controls. There is a large salt crystal in the middle of the negative HUVEC control and the 
cells in the upper corner appear to be lysed, but this was the best picture (figure 13c).
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There might be some indications of a concentration dependent uptake when comparing cells 
incubated with 0.5, 2 and 21 mM Si over 24 hours (figure 13), but the differences in color is not 
strong enough for a definite conclusion. The RAW264.7 cells appear darker and could therefore 
have taken up IXGp to a greater extent compared to the other two cell types. That the RAW264.7 
cells were more effective at internalizing nanoparticles compared to the other cells were clearly seen
in the SPIO uptake tests (figure 10) and Prussian Blue staining (figure 12) and to some degree in the
IXGp uptake tests (figure 11).
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Figure 13: Immunocytochemical staining of IXGp in RAW264.7, L929 and HUVEC cells incubated with various
concentrations of  IXGp for 24 hours. From left to right: RAW264.7, L929 and HUVEC cells. From top to 
bottom: Incubated concentrations of 0, 0.5, 2 and 21 mM Si (IXGp). Note the salt crystal in the center of figure 
c. 
Figure 14 shows RAW264.7, L929 and HUVEC cells incubated with 21 mM Si (IXGp) for 10 
minutes (d-f) and 24 hours (g-i). Two different types of negative controls are also depicted with cells
incubated with 21 mM Si for 24 hours, but without either anti-PEG antibodies or Tween 20. 
Without anti-PEG antibodies, the secondary antibodies conjugated to horseradish peroxidase should
not be able to bind and no brown color should be produced from DAB. Figure 14a-c show that 
unbound secondary antibodies effectively have been removed during the washing procedure. Tween 
permeabilizes the cell membranes, allowing the antibodies to enter the cells and bind to IXGp 
within. Cells without Tween serve as a control for particle adsorption. A similar coloration with or 
without Tween would mean that the particles mainly adhere to the surface rather than being 
internalized. 
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It looks like RAW264.7 cells internalize IXGp as cells treated with Tween (figure 14g) clearly show 
brown coloration inside the cells while cells without Tween show brown coloration only around the 
cells. However, L929 cells treated with or without Tween show no apparent differences. HUVEC 
cells treated with or without Tween are difficult to compare as there were few cells and the once 
seen often appeared in clumps of cells making it difficult to set the focus in the microscope. 
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Figure 14: Immunocytochemical staining of IXGp in RAW264.7, L929 and HUVEC cells incubated with IXGp. 
a-c: RAW264.7, L929 and HUVEC cells, respectively, incubated with 21 mM Si (IXGp) for 24 hours, but 
without anti-PEG antibodies. d-f: RAW264.7, L929 and HUVEC cells, respectively, incubated with 21 mM Si 
for 10 minutes. g-i:  RAW264.7, L929 and HUVEC cells, respectively, incubated with 21 mM Si for 24 hours. j-
l:  RAW264.7, L929 and HUVEC cells, respectively, incubated with 21 mM Si for 24 hours, but without Tween.
Again, there are no clear differences when comparing cells incubated with 21 mM Si (IXGp) for 10 
minutes (figure 14d-f) or 24 hours (figure 8g-i). Some slight difference might be seen in RAW264.7 
where a few cells incubated for 10 minutes are less brown, suggesting a time dependent uptake of 
IXGp. Thus there is most likely an internalization of IXGp particles in RAW264.7 cells, but it can 
not be confirmed in L929 or HUVEC cells.
Conclusions
This study shows that RAW264.7 and HepG2 cells and possibly L929 cells can internalize 10-12 
nm naked SPIO particles and that the uptake is time and concentration dependent. RAW264.7 cells 
and possibly Jurkat cells can take up 5 nm IXGp partices, but only when incubated with 
concentrations higher than intended for the clinic. RAW264.7 cells were over all more effective at 
internalizing nanoparticles than L929, HepG2, Jurkat and HUVEC cells. 
The metabolic activity of HepG2, RAW264.7, L929 and Jurkat cells were not negatively affected 
when incubated with up to 1.8 mM Fe (naked SPIO) or 21 mM Si (IXGp) for 24 hours. Instead, 
especially the RAW264.7 cells increased their metabolic activity markedly, up to 160% of control 
when treated with SPIO particles. HUVEC cells were over all more sensitive when handled in the 
tests and had a metabolic activity of 75% compared to the control, when incubated with up to 21 
mM Si (IXGp) for 24 hours. The metabolic activity of HUVEC cells was reduced down to 9% and 
the cells detached from the surface when incubated with 0.9 mM Fe for 24 hours. The HUVEC cells
might not have in a good state to begin with. 
Thus, apart from the difficulties with the HUVEC cells the precursor to the contrast agent Ion-X-Gel
seem to be well tolerated by L929, HepG2, Jurkat and RAW264.7 cells and appear to only be 
internalyzed to a very limited degree but to some greater extent by the RAW264.7 cells, not 
unexpected seeing as that is one of the things macrophages are designed for. This is a good 
indication that the final contrast agent, IXG might behave as intended, but more tests need to be 
done to fully evaluate the properties. 
Proposed Future Work
In future studies, it would be interesting to test more non-immortalized human cell lines, for 
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example HASMC and HMEC cells and see if they behave in the same way as the HUVEC cell line. 
It would also be interesting to further explore the time dependency. Incubation times up to 48 hours 
could be tested to determine when the cells reaches max uptake and the particles could be added 
with 30 minutes intervals during the first few hours to see when the uptake starts. If the uptake is 
energy dependent could be tested by incubating the cells in 4 °C to force them into growth arrest 
and stop the metabolic activity or by adding metabolic inhibitors to stop the production of ATP for 
example. If there is an energy dependance, particle internalization and adsorption could be tested by 
comparing the uptake in metabolically active cells with metabolically blocked cells. Uptake in 
tissue slices from, for example rat kidney, liver and aorta, would be interesting to study as cells in 
organs behave differently than in cell cultures. Further studies on the long term viability effect SPIO
and IXGp have on cells could be tested by incubating cells for a few days. It would also be 
interesting to analyze if the viability effects is permanent or if the cells will recover when the 
particles are removed. 
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Appendix 1
Figure 1: Relative fluorescence versus number of cells.
Figure 2: Uptake of SPIO nanoparticles in HepG2 cells. 24 hours after initial seeding, 
cells were incubated with various concentrations of SPIO for 24 hours or 10 minutes. 
Data has been normalized. Cells were grown in 24-well plates.
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Figure 3: Percentage mol Fe taken up in various cells treated with various 
concentrations of SPIO over 10 minutes or 24 hours. 
Figure 4: Uptake of IXGp in various cell lines incubated with various concentrations
of IXGp over 24 hours or 10 minutes. These data are markedly lower than seen in 
another setup with the same cells. Note that the negative control for the HepG2 cells 
fall outside the scale with a value of 75 nmol Si/million cells.
41
Figure 5: Percentage mol Si (IXGp) taken up in various cells treated with various 
concentrations of IXGp over 10 minutes or 24 hours. 
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